Asston Pharma Approves Management Remuneration Hikes & Auditor Appointment

Asston Pharmaceuticals Ltd announced key resolutions passed by its members during the 7th Annual General Meeting held on September 29, 2026. The company's members approved the adoption of audited standalone financial statements for the fiscal year ended March 31, 2026. Additionally, Mr. Ashish Narayan Sakalkar was re-appointed as Managing Director and Director retiring by rotation. The members also approved the appointment of M/s Panchal S K & Associates as the new Statutory Auditors. Furthermore, the company approved increases in remuneration for Mr. Ashish Narayan Sakalkar (Managing Director), Mrs. Saili Jayaram More (Whole-time Director and CEO), and Mr. Sachin Chandrakant Badakh (Non-Executive Director).